AUA Releases Clinical Guidelines for Interstitial Cystitis/Bladder Pain Syndrome

The American Urological Association released today a new clinical Guideline on the Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome to help aid physicians in diagnosing and treating patients who present with symptoms of IC/BPS, according to an association news release.

Advertisement

The new guideline is designed to present a clinical strategy for physicians. However, the guideline panel notes that the most effective approach for a specific case should be determined by the individual patient and their clinician.

In assessing patients, panel experts recommend a full basic assessment to identify characteristic IC/BPS symptoms and rule out confusable disorders; measurements of baseline voiding symptoms and pain levels; and consideration of cystoscopy and/or urodynamic studies to better assess patients or confirm a diagnosis.

The guideline also includes key clinical principles for first-line treatment of IC/BPS, including the use of the most conservative treatments before moving to less conservative therapies.

Read the news release about AUA’s Guideline on the Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome.

Read other coverage about healthcare associations:

OHA: 1 in 5 Patients Readmitted Within 30 Days

AORN Urges Safety During Six Phases of Medication Administration Process

AOHP’s No. 1 Concern: Bloodborne Pathogens

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.